During a press conference Tuesday at the International AIDS Conference in Vienna, Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases at NIH, describes the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial. The study is testing the safety and efficacy of microbicide gel containing the ARV drug tenofovir, and oral tablets containing tenofovir or a combination of tenofovir and emtricitabine known by the brand name Truvada.
The science is clear, HIV criminalization is abusive, discriminatory and counterproductive – The destructiveness of HIV-specific laws that fueled stigma and discouraged diagnosis by criminalizing people […]
49th Union World Conference on Lung Health: 90 percent of participants in short-course XDR-TB regimen cured after six months
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
So many lessons are offered in a recent communication from the U.S. Centers for Disease Control and Prevention about antibiotic-resistant infections among patients returning to the […]